FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226093663> ?p ?o ?g. }

• W4226093663 abstract "The study aimed to explore whether the expression of lncRNAs in primary tumors could predict nodal efficacy after neoadjuvant therapy (NAT) for HER2+ breast cancer.Total RNA was extracted from HER2+ breast cancer tissues before NAT (n=103) and from 48 pairs of cancers and para-cancers tissues that did not receive NAT. Different lncRNAs were selected by microarray, validated by qPCR, and analyzed to illuminate their potential as nodal efficacy biomarkers after NAT.Our results demonstrated that three lncRNA sets, lncRNA-AL390243.1, POTEH-AS1, and lncRNA-AC009975.1, were up-regulated in non-apCR tissues. The AUC value was 0.789 (95%CI: 0.703-0.876). The multivariate logistic regression analysis identified the expression of lncRNA-AL390243.1 (OR 5.143; 95% CI: 1.570-16.847), tumor type (OR 0.144; 95% CI: 0.024-0.855), and nodal stage (OR 0.507; 95% CI: 0.289-0.888) as independent predictors for apCR after NAT in HER2+ patients (all p<0.05). Then the three predictors were used to create a predictive nomogram. The AUC value was 0.859 (95%CI: 0.790-0.929). The calibration curve showed a satisfactory fit between predictive and actual observation based on internal validation with a bootstrap resampling frequency of 1000. Patients with higher expression of lncRNA-AL390243.1 had worse survival. LncRNA-AL390243.1 was up-regulated more in the nodal positive subgroup than in the nodal negative subgroup (p=0.0271).The lncRNA-AL390243.1, POTEH-AS1, and lncRNA-AC009975.1 were upregulated in non-apCR breast cancer tissues. These three lncRNAs might have the potential to be used as predictive biomarkers of nodal efficacy of HER2+ breast cancer. Further studies are required to illuminate the underlying molecular mechanisms further." @default.
• W4226093663 created "2022-05-05" @default.
• W4226093663 creator A5006742370 @default.
• W4226093663 creator A5010776860 @default.
• W4226093663 creator A5013652689 @default.
• W4226093663 creator A5026804113 @default.
• W4226093663 creator A5034571571 @default.
• W4226093663 creator A5059366112 @default.
• W4226093663 creator A5069202094 @default.
• W4226093663 creator A5070336583 @default.
• W4226093663 date "2021-12-06" @default.
• W4226093663 modified "2023-09-30" @default.
• W4226093663 title "A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer" @default.
• W4226093663 cites W1628452971 @default.
• W4226093663 cites W1987326983 @default.
• W4226093663 cites W2026828444 @default.
• W4226093663 cites W2045420997 @default.
• W4226093663 cites W2068517905 @default.
• W4226093663 cites W2075608400 @default.
• W4226093663 cites W2075894019 @default.
• W4226093663 cites W2121556235 @default.
• W4226093663 cites W2314065766 @default.
• W4226093663 cites W2346232596 @default.
• W4226093663 cites W2624590002 @default.
• W4226093663 cites W2736523376 @default.
• W4226093663 cites W2742282063 @default.
• W4226093663 cites W2757508861 @default.
• W4226093663 cites W2791151919 @default.
• W4226093663 cites W2792307454 @default.
• W4226093663 cites W2797461998 @default.
• W4226093663 cites W2801854368 @default.
• W4226093663 cites W2883114613 @default.
• W4226093663 cites W2915133036 @default.
• W4226093663 cites W3023029929 @default.
• W4226093663 cites W3044411636 @default.
• W4226093663 cites W3047845989 @default.
• W4226093663 cites W3155569912 @default.
• W4226093663 cites W3165174637 @default.
• W4226093663 cites W3179495039 @default.
• W4226093663 cites W4255641164 @default.
• W4226093663 cites W4256554205 @default.
• W4226093663 doi "https://doi.org/10.3389/fonc.2021.779140" @default.
• W4226093663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34938660" @default.
• W4226093663 hasPublicationYear "2021" @default.
• W4226093663 type Work @default.
• W4226093663 citedByCount "1" @default.
• W4226093663 countsByYear W42260936632023 @default.
• W4226093663 crossrefType "journal-article" @default.
• W4226093663 hasAuthorship W4226093663A5006742370 @default.
• W4226093663 hasAuthorship W4226093663A5010776860 @default.
• W4226093663 hasAuthorship W4226093663A5013652689 @default.
• W4226093663 hasAuthorship W4226093663A5026804113 @default.
• W4226093663 hasAuthorship W4226093663A5034571571 @default.
• W4226093663 hasAuthorship W4226093663A5059366112 @default.
• W4226093663 hasAuthorship W4226093663A5069202094 @default.
• W4226093663 hasAuthorship W4226093663A5070336583 @default.
• W4226093663 hasBestOaLocation W42260936631 @default.
• W4226093663 hasConcept C121608353 @default.
• W4226093663 hasConcept C126322002 @default.
• W4226093663 hasConcept C143998085 @default.
• W4226093663 hasConcept C146357865 @default.
• W4226093663 hasConcept C151730666 @default.
• W4226093663 hasConcept C151956035 @default.
• W4226093663 hasConcept C182516595 @default.
• W4226093663 hasConcept C2778292576 @default.
• W4226093663 hasConcept C2781197716 @default.
• W4226093663 hasConcept C31258907 @default.
• W4226093663 hasConcept C34626388 @default.
• W4226093663 hasConcept C38180746 @default.
• W4226093663 hasConcept C41008148 @default.
• W4226093663 hasConcept C530470458 @default.
• W4226093663 hasConcept C55493867 @default.
• W4226093663 hasConcept C71924100 @default.
• W4226093663 hasConcept C86803240 @default.
• W4226093663 hasConceptScore W4226093663C121608353 @default.
• W4226093663 hasConceptScore W4226093663C126322002 @default.
• W4226093663 hasConceptScore W4226093663C143998085 @default.
• W4226093663 hasConceptScore W4226093663C146357865 @default.
• W4226093663 hasConceptScore W4226093663C151730666 @default.
• W4226093663 hasConceptScore W4226093663C151956035 @default.
• W4226093663 hasConceptScore W4226093663C182516595 @default.
• W4226093663 hasConceptScore W4226093663C2778292576 @default.
• W4226093663 hasConceptScore W4226093663C2781197716 @default.
• W4226093663 hasConceptScore W4226093663C31258907 @default.
• W4226093663 hasConceptScore W4226093663C34626388 @default.
• W4226093663 hasConceptScore W4226093663C38180746 @default.
• W4226093663 hasConceptScore W4226093663C41008148 @default.
• W4226093663 hasConceptScore W4226093663C530470458 @default.
• W4226093663 hasConceptScore W4226093663C55493867 @default.
• W4226093663 hasConceptScore W4226093663C71924100 @default.
• W4226093663 hasConceptScore W4226093663C86803240 @default.
• W4226093663 hasFunder F4320321001 @default.
• W4226093663 hasLocation W42260936631 @default.
• W4226093663 hasLocation W42260936632 @default.
• W4226093663 hasLocation W42260936633 @default.
• W4226093663 hasLocation W42260936634 @default.
• W4226093663 hasLocation W42260936635 @default.
• W4226093663 hasOpenAccess W4226093663 @default.
• W4226093663 hasPrimaryLocation W42260936631 @default.
• W4226093663 hasRelatedWork W2050875047 @default.

• next